that in a small series of experiments carried out with clones produced by Dr. I. Lefkovits at the Base1 Institute for Immunology, and using mixed sheep RBC indicators, I could find no evidence of mixed clones. Yet, there was no doubt of their occurrence under apparently similar conditions in Canberra, Australia. It seems probable that rate of variation is influenced by factors which we are not controlling. I agree with Dr. Shortman that the rate of variation is likely to be more rapid the earlier (in clonal ontogeny) one looks. The ultimate question is of course how much post-antigenic variation occurs in vivo during normal immune responses. We have also reported other kinds of experiments (summarized in [2]), some performed in vivo, and have attempted to marshal arguments to support the idea that such variation is common in real life.
Laboratoire d'Immunologie et Virologie des Tumeurs, INSERM U-152, HCipital Cochin, ParisThe FMR antigen is currently defined as a cell surface antigen shared by Moloney, Rauscher, Friend and Graffi virus-induced leukemias. Different groups have reported contradictory results showing an association of FMR either with various internal or external virion components or with a nonvirion protein. A study of twelve supposed anti-FMR antisera using complement-dependent cytotoxicity assays, and quantitative absorption of their activity on different lymphoma cells show that there exists an "FMR system" rather than an FMR antigen. Several antigenic specificities can be defined which are either common to all the leukemia tested (FMRGi) or limited to the lymphomas induced by certain viruses. In the latter group, at least F, FR, and MRGi antigens can be distinguished. These "FMR antigens" are frequently associated at the lymphoma cell surface with non-FMR specificities. The so-called anti-FMR antisera show a variable specificity pattern generally revealing some but not all of the FMR antigens. Many of them do not contain anti-FMRGi antibodies. On the contrary, they can react against non-FMR antigens. Cocapping experiments reveal a comigration of the common FMRGi antigen and the major viral glycoprotein, gp69/ 71. Absorption of anti-FMRGi activity by both Rauscher or Moloney virions and by purified Rauscher gp69/71 confirm this result suggesting that FMRGi could be a subgroup specificity of the gp69/71 of exogenous type C viruses. The nature of the other FMR specificity was not studied here. The complexicity of the FMR system probably explains the contradictory results which have been published concerning the nature of FMR antigens. It is probable that several antigens have been studied by different groups under the same name. Very precise technical conditions must be used for the analysis of the FMR system if such confusion is to be avoided in the future.